BACKGROUND: The extracellular matrix represents a major barrier for drug delivery. This work compares the effects of collagenase and hyaluronidase on tumour uptake and distribution of two differently sized therapeutic molecules, IgG and liposomal doxorubicin. MATERIALS AND METHODS: The enzymes were injected i.v. prior to the therapeutic molecules, and uptake and distribution were studied by confocal laser scanning microscopy. The therapeutic molecules were colocalized with the vasculature and collagen network visualized by the second harmonic signal. RESULTS: Hyaluronidase increased the uptake of liposomal doxorubicin to a small extent, whereas collagenase had no effect. Collagenase increased, but hyaluronidase reduced the uptake of IgG. Neither of the enzymes induced changes in the collagen network measured by the second harmonic signal. CONCLUSION: Degradation of the collagen network improves delivery of molecules with the size of IgG, whereas degradation of the gel of glycosaminoglycans has a higher impact on the distribution of small drugs such as doxorubicin.
BACKGROUND: The extracellular matrix represents a major barrier for drug delivery. This work compares the effects of collagenase and hyaluronidase on tumour uptake and distribution of two differently sized therapeutic molecules, IgG and liposomal doxorubicin. MATERIALS AND METHODS: The enzymes were injected i.v. prior to the therapeutic molecules, and uptake and distribution were studied by confocal laser scanning microscopy. The therapeutic molecules were colocalized with the vasculature and collagen network visualized by the second harmonic signal. RESULTS: Hyaluronidase increased the uptake of liposomal doxorubicin to a small extent, whereas collagenase had no effect. Collagenase increased, but hyaluronidase reduced the uptake of IgG. Neither of the enzymes induced changes in the collagen network measured by the second harmonic signal. CONCLUSION: Degradation of the collagen network improves delivery of molecules with the size of IgG, whereas degradation of the gel of glycosaminoglycans has a higher impact on the distribution of small drugs such as doxorubicin.
Authors: Jessie L-S Au; Bertrand Z Yeung; Michael G Wientjes; Ze Lu; M Guillaume Wientjes Journal: Adv Drug Deliv Rev Date: 2015-12-11 Impact factor: 15.470
Authors: Surya Murty; Taylor Gilliland; Peter Qiao; Tate Tabtieng; Elizabeth Higbee; Ajlan Al Zaki; Ellen Puré; Andrew Tsourkas Journal: Part Part Syst Charact Date: 2014-12 Impact factor: 3.310
Authors: Sjoerd Hak; Jana Cebulla; Else Marie Huuse; Catharina de L Davies; Willem J M Mulder; Henrik B W Larsson; Olav Haraldseth Journal: Angiogenesis Date: 2013-08-27 Impact factor: 9.596
Authors: Yiming Zhao; Inge van Rooy; Sjoerd Hak; Francois Fay; Jun Tang; Catharina de Lange Davies; Mihaela Skobe; Edward Allen Fisher; Aurelian Radu; Zahi A Fayad; Celso de Mello Donegá; Andries Meijerink; Willem J M Mulder Journal: ACS Nano Date: 2013-10-24 Impact factor: 15.881
Authors: Kenji Yokoi; Tomonori Tanei; Biana Godin; Anne L van de Ven; Masaki Hanibuchi; Aika Matsunoki; Jenolyn Alexander; Mauro Ferrari Journal: Cancer Lett Date: 2013-12-24 Impact factor: 8.679